Jill Dayan, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 31 Cortlandt Manor Rd, Katonah, NY 10536 Phone: 914-232-5693 Fax: 914-232-7408 |
News Archive
A new walk-through coronavirus testing facility has opened for those with symptoms to book appointments at Beach Street Car Park West (LL57 1AT) in Bangor, as part of the UK Government's UK-wide drive to continue to improve the accessibility of coronavirus testing for local communities.
Politics continue to swirl around health overhaul and deficit reduction issues. A new Bloomberg poll, for instance, indicates that the public wants the deficit addressed, but still wants Congress to stay away from Medicare, Medicaid and other entitlement programs. Meanwhile, a GOP senator targets the catch-all spending bill to fund the government as a "trojan horse" to fund the health overhaul. Off the hill, groups are paying particular attention to the words used in discussing health policy issues.
Health officials from 16 countries today asked for budgetary support "to ensure the sustainability of the existing vaccination programs and the introduction of new vaccines," at the conclusion of a global symposium on rotavirus, a diarrheal disease that kills over 600,000 children worldwide every year.
Delcath Systems, Inc. a development stage, specialty pharmaceutical and medical device company focused on oncology, highlighted the Phase III trial data presented on June 5 at the American Society of Clinical Oncology's 2010 Annual Meeting, comparing percutaneous hepatic perfusion with melphalan to the best alternative care for patients with hepatic metastases from ocular or cutaneous melanoma.
Teva Pharmaceutical Industries Ltd. announced today that it has received a complete response letter from the U.S. Food and Drug Administration (FDA) for its supplemental New Drug Application (sNDA) for a lower-volume (0.5mL) injection of glatiramer acetate. Copaxone® containing 20mg of glatiramer acetate in 1ml is the global market leader in the treatment of relapsing-remitting multiple sclerosis (RRMS).
› Verified 9 days ago